Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death

Donation after cardiac death (DCD) has expanded in the last decade in the US; however, DCD liver utilization has flattened in recent years due to poor outcomes. We examined clinical and quality of life (QOL) outcomes of DCD recipients by conducting a retrospective and cross-sectional review of patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Neehar D. Parikh, Anton I. Skaro, Daniela P. Ladner, Vadim Lyuksemburg, Joshua G. Cahan, Amna Daud, Zeeshan Butt
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/680316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547548561145856
author Neehar D. Parikh
Anton I. Skaro
Daniela P. Ladner
Vadim Lyuksemburg
Joshua G. Cahan
Amna Daud
Zeeshan Butt
author_facet Neehar D. Parikh
Anton I. Skaro
Daniela P. Ladner
Vadim Lyuksemburg
Joshua G. Cahan
Amna Daud
Zeeshan Butt
author_sort Neehar D. Parikh
collection DOAJ
description Donation after cardiac death (DCD) has expanded in the last decade in the US; however, DCD liver utilization has flattened in recent years due to poor outcomes. We examined clinical and quality of life (QOL) outcomes of DCD recipients by conducting a retrospective and cross-sectional review of patients from 2003 to 2010. We compared clinical outcomes of DCD recipients (n=60) to those of donation after brain death (DBD) liver recipients (n=669) during the same time period. DCD recipients had significantly lower rates of 5-year graft survival (P<0.001) and a trend toward lower rates of 5-year patient survival (P=0.064) when compared to the DBD cohort. In order to examine QOL outcomes in our cohorts, we administered the Short Form Liver Disease Quality of Life questionnaire to 30 DCD and 60 DBD recipients. The DCD recipients reported lower generic and liver-specific QOL. We further stratified the DCD cohort by the presence of ischemic cholangiopathy (IC). Patients with IC reported lower QOL when compared to DBD recipients and those DCD recipients without IC (P<0.05). While the results are consistent with clinical experience, this is the first report of QOL in DCD recipients using standardized measures. These data can be used to guide future comparative effectiveness studies.
format Article
id doaj-art-0bfc39e45d224d1aafbe62f5c6222152
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-0bfc39e45d224d1aafbe62f5c62221522025-02-03T06:44:13ZengWileyGastroenterology Research and Practice1687-61211687-630X2015-01-01201510.1155/2015/680316680316Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac DeathNeehar D. Parikh0Anton I. Skaro1Daniela P. Ladner2Vadim Lyuksemburg3Joshua G. Cahan4Amna Daud5Zeeshan Butt6Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USANorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Northwestern University, Chicago, IL 60611, USADonation after cardiac death (DCD) has expanded in the last decade in the US; however, DCD liver utilization has flattened in recent years due to poor outcomes. We examined clinical and quality of life (QOL) outcomes of DCD recipients by conducting a retrospective and cross-sectional review of patients from 2003 to 2010. We compared clinical outcomes of DCD recipients (n=60) to those of donation after brain death (DBD) liver recipients (n=669) during the same time period. DCD recipients had significantly lower rates of 5-year graft survival (P<0.001) and a trend toward lower rates of 5-year patient survival (P=0.064) when compared to the DBD cohort. In order to examine QOL outcomes in our cohorts, we administered the Short Form Liver Disease Quality of Life questionnaire to 30 DCD and 60 DBD recipients. The DCD recipients reported lower generic and liver-specific QOL. We further stratified the DCD cohort by the presence of ischemic cholangiopathy (IC). Patients with IC reported lower QOL when compared to DBD recipients and those DCD recipients without IC (P<0.05). While the results are consistent with clinical experience, this is the first report of QOL in DCD recipients using standardized measures. These data can be used to guide future comparative effectiveness studies.http://dx.doi.org/10.1155/2015/680316
spellingShingle Neehar D. Parikh
Anton I. Skaro
Daniela P. Ladner
Vadim Lyuksemburg
Joshua G. Cahan
Amna Daud
Zeeshan Butt
Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
Gastroenterology Research and Practice
title Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
title_full Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
title_fullStr Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
title_full_unstemmed Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
title_short Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
title_sort clinical outcomes and quality of life in recipients of livers donated after cardiac death
url http://dx.doi.org/10.1155/2015/680316
work_keys_str_mv AT neehardparikh clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT antoniskaro clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT danielapladner clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT vadimlyuksemburg clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT joshuagcahan clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT amnadaud clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath
AT zeeshanbutt clinicaloutcomesandqualityoflifeinrecipientsofliversdonatedaftercardiacdeath